Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Ann Oncol
2025
36
2
185-196
Development and optimization of an integrated exercise and nutrition program for ovarian cancer patients: Phase I of the BENITA multi-center study.
Gynecol Oncol
2025
202
167-173
PSMF1 variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways.
medRxiv
2024
Loss of CELSR1 and impaired Wnt/planar cell polarity signaling cause yellow nail syndrome
Eur J Hum Genet
2025
33 Suppl 1
87-87
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
J Clin Oncol
2025
43 Suppl 17_SUPPL
17_SUPPL
LBA5500-LBA5500
Local Perforator Flaps in Oncoplastic Breast Surgery: Clinical Applications of ICAP and TDAP Flaps in Reconstruction and Complication Management.
Geburtsh Frauenheilk
2026
86
1
45-55
Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo-Oophorectomy in BRCA1/2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center.
Cancer Med
2026
15
3
Elucidating the effect of the Mediterranean diet on fecal bile acids and their mediating role on biomarkers of intestinal barrier function: An exploratory analysis of a randomized controlled trial.
Life Sci
2025
379
Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study: A Quality Assurance Initiative of the AGO-Study Group and AGO-OK Uterus.
Geburtsh Frauenheilk
2025
85
5
520-532